HucMSC-Ex通过调节肠上皮细胞中RACK1的O-GlcNAcylation修饰来缓解炎症性肠病

相关实验视频

Updated: Jul 20, 2026

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4⁺ T Cells to Immunodeficient Mice

Published on: December 16, 2021

Ziyue Liu¹, Jintao Yuan², Muhammad AzharUd Din¹

¹Department of Laboratory Medicine, the Affiliated People's Hospital, Jiangsu University, Zhenjiang, Jiangsu 212002, PR China.

Colloids and surfaces. B, Biointerfaces

|March 11, 2025

概括

人类带介质干细胞衍生外体 (HucMSC-Ex) 显示出治疗炎症性肠病 (IBD) 的前景. 它们通过修改O-GlcNAc糖化,减少炎症和促进肠道愈合来缓解IBD.

科学领域:

胃肠病学胃肠病学
免疫学免疫学免疫学
再生医学是一种再生医学.

背景情况:

炎症性肠病 (IBD) 是一种慢性自身免疫性疾病,影响胃肠道,治疗选择有限.
了解IBD病原体背后的分子机制对于开发有效疗法至关重要.

研究的目的:

研究人类带介质干细胞衍生的外体细胞 (HucMSC-Ex) 在缓解IBD方面的治疗潜力.
阐明O-GlcNAc糖化,特别是RACK1蛋白在HucMSC-Ex介导IBD治疗中的作用.

主要方法:

在体外和体外模型被用来评估HucMSC-Ex对IBD的影响.
分析的重点是调节促炎因素,肠上皮细胞再生和O-GlcNAc糖化水平.
这项研究研究了对表皮-介质细胞转换 (EMT) 和RACK1蛋白质糖化.

主要成果:

HucMSC-Ex在小鼠肠道上皮细胞中显著抑制了促炎因素.
HucMSC-Ex促进了肠上皮细胞的再生,并逆转了EMT.
O-GlcNAc糖化水平的升高,特别是RACK1,与治疗效果相关.

结论:

通过调节O-GlcNAc糖化,HucMSC-Ex有效地减轻IBD症状和炎症反应.
这种机制涉及EMT的逆转和促进肠道愈合.
HucMSC-Ex为IBD提供了一种新的治疗策略,影响免疫调节和肠道微生物群.

关键词:

在EMT中,EMT是EMT.这就是HucMSC-Ex.IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD 这就是O-GLcNAcc.在RACK1中,使用RACK1.

更多相关视频

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine

Published on: October 13, 2023

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

相关概念视频

Hedgehog Signaling Pathway

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...

Renewal of Intestinal Stem Cells

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

Drugs for Treatment of Ulcerative Colitis in IBD

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...